Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Plasmodium falciparum | M18 aspartyl aminopeptidase | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | Clan MH, family M18, aspartyl aminopeptidase-like metallopeptidase | 0.0087 | 0.2625 | 0.2625 |
Trypanosoma cruzi | aspartyl aminopeptidase, putative | 0.0087 | 0.2625 | 1 |
Echinococcus multilocularis | aspartyl aminopeptidase | 0.0087 | 0.2625 | 0.3054 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0041 | 0.0293 | 0.0293 |
Trypanosoma brucei | aspartyl aminopeptidase, putative | 0.0087 | 0.2625 | 1 |
Echinococcus granulosus | aspartyl aminopeptidase | 0.0087 | 0.2625 | 0.3054 |
Entamoeba histolytica | aminopeptidase, putative | 0.0087 | 0.2625 | 0.5 |
Trypanosoma brucei | aspartyl aminopeptidase, putative | 0.0087 | 0.2625 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0087 | 0.2625 | 0.3062 |
Schistosoma mansoni | aspartyl aminopeptidase (M18 family) | 0.0087 | 0.2625 | 0.3054 |
Schistosoma mansoni | aspartyl aminopeptidase (M18 family) | 0.0087 | 0.2625 | 0.3054 |
Mycobacterium ulcerans | hypothetical protein | 0.0035 | 0 | 0.5 |
Plasmodium falciparum | M18 aspartyl aminopeptidase | 0.0087 | 0.2625 | 0.5 |
Mycobacterium ulcerans | beta-lactamase | 0.0035 | 0 | 0.5 |
Plasmodium vivax | M18 aspartyl aminopeptidase, putative | 0.0087 | 0.2625 | 1 |
Mycobacterium ulcerans | lipase LipD | 0.0035 | 0 | 0.5 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0204 | 0.8572 | 1 |
Toxoplasma gondii | ABC1 family protein | 0.0035 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.8593 | 1 |
Loa Loa (eye worm) | aspartyl aminopeptidase | 0.0087 | 0.2625 | 0.3062 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.8593 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0041 | 0.0293 | 0.0293 |
Leishmania major | aspartyl aminopeptidase, putative,metallo-peptidase, Clan MH, Family M20 | 0.0087 | 0.2625 | 1 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0223 | 0.9506 | 1 |
Echinococcus granulosus | geminin | 0.0205 | 0.8593 | 1 |
Trichomonas vaginalis | Clan MH, family M18, aspartyl aminopeptidase-like metallopeptidase | 0.0087 | 0.2625 | 0.2625 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0041 | 0.0293 | 0.0293 |
Entamoeba histolytica | aspartyl aminopeptidase, putative | 0.0087 | 0.2625 | 0.5 |
Trichomonas vaginalis | set domain proteins, putative | 0.0232 | 1 | 1 |
Trichomonas vaginalis | Clan MH, family M18, aspartyl aminopeptidase-like metallopeptidase | 0.0041 | 0.0293 | 0.0293 |
Mycobacterium tuberculosis | Probable aminopeptidase PepC | 0.0087 | 0.2625 | 0.2761 |
Echinococcus multilocularis | geminin | 0.0205 | 0.8593 | 1 |
Trichomonas vaginalis | hypothetical protein | 0.0041 | 0.0293 | 0.0293 |
Loa Loa (eye worm) | hypothetical protein | 0.0087 | 0.2625 | 0.3062 |
Trichomonas vaginalis | Clan MH, family M18, aspartyl aminopeptidase-like metallopeptidase | 0.0087 | 0.2625 | 0.2625 |
Brugia malayi | Aspartyl aminopeptidase | 0.0087 | 0.2625 | 0.3062 |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.0035 | 0 | 0.5 |
Brugia malayi | Pre-SET motif family protein | 0.0204 | 0.8572 | 1 |
Trichomonas vaginalis | Clan MH, family M18, aspartyl aminopeptidase-like metallopeptidase | 0.0041 | 0.0293 | 0.0293 |
Trypanosoma cruzi | metallo-peptidase, Clan MH, Family M20 | 0.0087 | 0.2625 | 1 |
Trichomonas vaginalis | Clan MH, family M18, aspartyl aminopeptidase-like metallopeptidase | 0.0041 | 0.0293 | 0.0293 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.0035 | 0 | 0.5 |
Mycobacterium leprae | PROBABLE AMINOPEPTIDASE PEPC | 0.0087 | 0.2625 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.93 um | PUBCHEM_BIOASSAY: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP). (Class of assay: confirmatory) [Related PubChem assays: 2170 (Confirmation screen (PFM18AAP inhibitors).), 1855 (Summary AID.)] | ChEMBL. | No reference |
IC50 (binding) | > 59.642 um | PUBCHEM_BIOASSAY: QFRET-based counterscreen for inhibitors of PFM18AAP: biochemical high throughput dose response assay for inhibitors of the Cathepsin L proteinase (CTSL1). (Class of assay: confirmatory) [Related pubchem assays: 2178 (Confirmation screen (PFM18AAP inhibitors).), 1855 (Summary AID.)] | ChEMBL. | No reference |
Potency (functional) | 0.1636 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | 25.1189 uM | PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 70.7946 uM | PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.